OTC and hyperinsulinemic hypoglycemia, familial, 4: Enzymatic defects include N-acetylglutamate synthase deficiency (NAGSD; MIM#237310), carbamoylphosphate synthetase 1 deficiency (CPS1D; MIM#237300), ornithine transcarbamylase deficiency (OTCD; MIM#311250), argininosuccinate synthetase deficiency (ASSD; MIM#215700), argininosuccinate lyase deficiency (ASLD; MIM#207900), and arginase 1 deficiency (ARG1D; MIM#207800).